Detalhe da pesquisa
1.
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.
PLoS Pathog;
19(8): e1011614, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37651466
2.
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
Sci Transl Med;
16(741): eadl2055, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38569014
3.
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo.
bioRxiv;
2023 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37131711
4.
Mild SARS-CoV-2 infection results in long-lasting microbiota instability.
mBio;
14(4): e0088923, 2023 08 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37294090
5.
Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination.
Emerg Microbes Infect;
12(2): 2270071, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37869789
6.
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic.
Pathogens;
11(6)2022 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35745509
7.
Mild SARS-CoV-2 infection results in long-lasting microbiota instability.
bioRxiv;
2022 Dec 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36523400